{"id":17720,"date":"2026-02-06T10:31:52","date_gmt":"2026-02-06T10:31:52","guid":{"rendered":"https:\/\/riaabarkergillette.com\/pk\/?p=17720"},"modified":"2026-02-06T10:39:23","modified_gmt":"2026-02-06T10:39:23","slug":"riaa-wins-pharmaceutical-tax-exemption-case","status":"publish","type":"post","link":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/","title":{"rendered":"RIAA Wins Pharmaceutical Tax Exemption Case"},"content":{"rendered":"\n

The Appellate Tribunal Inland Revenue (Karachi Bench) recently issued a significant judgment in favour of our client, a leading pharmaceutical multinational, concerning the applicability of a pharmaceutical tax exemption under SRO 551(I)\/2008<\/a>. The dispute centred on whether medicated shampoos and certain health salts qualified for tax exemptions reserved for registered drugs and medicaments.<\/p>\n\n\n\n

Background and Dispute<\/strong><\/p>\n\n\n\n

The tax authorities had raised a substantial demand, arguing that the client’s products did not qualify for exemptions under Serial No. 7 of the SRO. The Revenue Department contended that the word “and” in the notification required a substance to be both a registered drug under the Drugs Act, 1976 and a medicament under the Customs Act, 1969 to qualify for the exemption. Additionally, authorities sought to classify medicated shampoos as “cosmetics and toilet preparations,” which are expressly excluded from tax-exempt status.<\/p>\n\n\n\n

Legal Arguments<\/strong><\/p>\n\n\n\n

Our team advanced two principal arguments before the Tribunal. First, we demonstrated that the term “and” in the SRO must be read disjunctively (as “or”) to avoid legal absurdity and redundancy\u2014a principle firmly supported by Supreme Court precedents. Second, we presented detailed clinical literature establishing that the medicated shampoos are specifically formulated to treat serious dermatological conditions including psoriasis and eczema. Consequently, their therapeutic purpose distinguishes them from ordinary cosmetic products.<\/p>\n\n\n\n

Tribunal’s Decision<\/strong><\/p>\n\n\n\n

The Tribunal accepted our arguments and ruled that a product registered as a drug does not become a cosmetic simply because it can also be used for cleansing. It subsequently annulled the demand for sales tax, default surcharges, and penalties. This judgment will have wide-ranging implications for the consumer health industry, as many brands had previously accepted under regulatory pressure that this pharmaceutical tax exemption was unavailable to them.<\/p>\n\n\n\n

\n

“This judgment provides much-needed clarity on the interpretation of tax exemptions, ensuring that therapeutic products are not misclassified for revenue purposes,” said Shahbakht Pirzada<\/a> (Partner \u2013 Pakistan).<\/p>\n<\/blockquote>\n\n\n\n

For more information on navigating complex tax disputes or pharmaceutical regulations, contact Shahbakht Pirzada<\/a> today.<\/strong>
<\/p>\n\n\n\n

This article is not legal advice; it provides information of general interest about current legal issues.<\/em><\/p>\n\n\n\n

\u2026<\/p>\n\n\n\n

RIAA Barker Gillette is Pakistan\u2019s premier law firm, with an on-the-ground presence in three major cities in Pakistan: Karachi, Islamabad and Lahore, and affiliated offices in Dubai (DIFC) and London. <\/p>\n\n\n\n

The firm practices in all areas of corporate, commercial and dispute resolution law. Leading international legal directories consistently recognise the firm as a top-tier law firm in Pakistan.<\/p>\n\n\n\n

\"RIAA<\/figure>\n\n\n\n

RIAA Barker Gillette is the exclusive member firm in Pakistan for Lex Mundi<\/a>, the world\u2019s leading network of independent law firms with in-depth experience in over 125 countries worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"

The Appellate Tribunal Inland Revenue (Karachi Bench) ruled in favour of a leading pharmaceutical multinational, clarifying the scope of sales tax exemptions for therapeutic products. This landmark pharmaceutical tax exemption judgment annulled demands for sales tax, default surcharges, and penalties.<\/p>\n","protected":false},"author":9,"featured_media":17725,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":""},"categories":[9],"tags":[13,63,65],"class_list":["post-17720","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-story","tag-dispute-resolution","tag-pharmaceutical","tag-pharmaceutical-healthcare-and-life-sciences"],"acf":[],"yoast_head":"\nRIAA Wins Pharmaceutical Tax Exemption Case - RIAA Barker Gillette RIAA Wins Pharmaceutical Tax Exemption Case<\/title>\n<meta name=\"description\" content=\"RIAA secures landmark pharmaceutical tax exemption ruling for multinational client at Appellate Tribunal Inland Revenue Karachi.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RIAA Wins Pharmaceutical Tax Exemption Case - RIAA Barker Gillette RIAA Wins Pharmaceutical Tax Exemption Case\" \/>\n<meta property=\"og:description\" content=\"RIAA secures landmark pharmaceutical tax exemption ruling for multinational client at Appellate Tribunal Inland Revenue Karachi.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/\" \/>\n<meta property=\"og:site_name\" content=\"RIAA Barker Gillette\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-06T10:31:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-06T10:39:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2026\/02\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"720\" \/>\n\t<meta property=\"og:image:height\" content=\"405\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mayhar Kazi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mayhar Kazi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/\"},\"author\":{\"name\":\"Mayhar Kazi\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#\\\/schema\\\/person\\\/45cef49fa13e3c1a6c7c7b7e53d6a34b\"},\"headline\":\"RIAA Wins Pharmaceutical Tax Exemption Case\",\"datePublished\":\"2026-02-06T10:31:52+00:00\",\"dateModified\":\"2026-02-06T10:39:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/\"},\"wordCount\":449,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/assets\\\/uploads\\\/2026\\\/02\\\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png\",\"keywords\":[\"Dispute Resolution\",\"Pharmaceutical\",\"Pharmaceutical healthcare and life sciences\"],\"articleSection\":[\"news story\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/\",\"name\":\"RIAA Wins Pharmaceutical Tax Exemption Case - RIAA Barker Gillette RIAA Wins Pharmaceutical Tax Exemption Case\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/assets\\\/uploads\\\/2026\\\/02\\\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png\",\"datePublished\":\"2026-02-06T10:31:52+00:00\",\"dateModified\":\"2026-02-06T10:39:23+00:00\",\"description\":\"RIAA secures landmark pharmaceutical tax exemption ruling for multinational client at Appellate Tribunal Inland Revenue Karachi.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/#primaryimage\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/assets\\\/uploads\\\/2026\\\/02\\\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png\",\"contentUrl\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/assets\\\/uploads\\\/2026\\\/02\\\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png\",\"width\":720,\"height\":405},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/news-story\\\/riaa-wins-pharmaceutical-tax-exemption-case\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RIAA Wins Pharmaceutical Tax Exemption Case\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#website\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/\",\"name\":\"RIAA Barker Gillette\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#organization\",\"name\":\"RIAA Barker Gillette\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/assets\\\/uploads\\\/2025\\\/11\\\/eSignature_RBG_Logo.png\",\"contentUrl\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/assets\\\/uploads\\\/2025\\\/11\\\/eSignature_RBG_Logo.png\",\"width\":85,\"height\":72,\"caption\":\"RIAA Barker Gillette\"},\"image\":{\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/riaabarkergillette.com\\\/pk\\\/#\\\/schema\\\/person\\\/45cef49fa13e3c1a6c7c7b7e53d6a34b\",\"name\":\"Mayhar Kazi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a4e6997fee70574dadadba04bb3989eccddf86eb22d87b64e89372cb500e5b2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a4e6997fee70574dadadba04bb3989eccddf86eb22d87b64e89372cb500e5b2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a4e6997fee70574dadadba04bb3989eccddf86eb22d87b64e89372cb500e5b2?s=96&d=mm&r=g\",\"caption\":\"Mayhar Kazi\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RIAA Wins Pharmaceutical Tax Exemption Case - RIAA Barker Gillette RIAA Wins Pharmaceutical Tax Exemption Case","description":"RIAA secures landmark pharmaceutical tax exemption ruling for multinational client at Appellate Tribunal Inland Revenue Karachi.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/","og_locale":"en_US","og_type":"article","og_title":"RIAA Wins Pharmaceutical Tax Exemption Case - RIAA Barker Gillette RIAA Wins Pharmaceutical Tax Exemption Case","og_description":"RIAA secures landmark pharmaceutical tax exemption ruling for multinational client at Appellate Tribunal Inland Revenue Karachi.","og_url":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/","og_site_name":"RIAA Barker Gillette","article_published_time":"2026-02-06T10:31:52+00:00","article_modified_time":"2026-02-06T10:39:23+00:00","og_image":[{"width":720,"height":405,"url":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2026\/02\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png","type":"image\/png"}],"author":"Mayhar Kazi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mayhar Kazi","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/#article","isPartOf":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/"},"author":{"name":"Mayhar Kazi","@id":"https:\/\/riaabarkergillette.com\/pk\/#\/schema\/person\/45cef49fa13e3c1a6c7c7b7e53d6a34b"},"headline":"RIAA Wins Pharmaceutical Tax Exemption Case","datePublished":"2026-02-06T10:31:52+00:00","dateModified":"2026-02-06T10:39:23+00:00","mainEntityOfPage":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/"},"wordCount":449,"commentCount":0,"publisher":{"@id":"https:\/\/riaabarkergillette.com\/pk\/#organization"},"image":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/#primaryimage"},"thumbnailUrl":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2026\/02\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png","keywords":["Dispute Resolution","Pharmaceutical","Pharmaceutical healthcare and life sciences"],"articleSection":["news story"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/","url":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/","name":"RIAA Wins Pharmaceutical Tax Exemption Case - RIAA Barker Gillette RIAA Wins Pharmaceutical Tax Exemption Case","isPartOf":{"@id":"https:\/\/riaabarkergillette.com\/pk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/#primaryimage"},"image":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/#primaryimage"},"thumbnailUrl":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2026\/02\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png","datePublished":"2026-02-06T10:31:52+00:00","dateModified":"2026-02-06T10:39:23+00:00","description":"RIAA secures landmark pharmaceutical tax exemption ruling for multinational client at Appellate Tribunal Inland Revenue Karachi.","breadcrumb":{"@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/#primaryimage","url":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2026\/02\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png","contentUrl":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2026\/02\/NEWS-Landmark-tax-Exemption-win-for-pharma-multinational-1.png","width":720,"height":405},{"@type":"BreadcrumbList","@id":"https:\/\/riaabarkergillette.com\/pk\/news-story\/riaa-wins-pharmaceutical-tax-exemption-case\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/riaabarkergillette.com\/pk\/"},{"@type":"ListItem","position":2,"name":"RIAA Wins Pharmaceutical Tax Exemption Case"}]},{"@type":"WebSite","@id":"https:\/\/riaabarkergillette.com\/pk\/#website","url":"https:\/\/riaabarkergillette.com\/pk\/","name":"RIAA Barker Gillette","description":"","publisher":{"@id":"https:\/\/riaabarkergillette.com\/pk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/riaabarkergillette.com\/pk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/riaabarkergillette.com\/pk\/#organization","name":"RIAA Barker Gillette","url":"https:\/\/riaabarkergillette.com\/pk\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/riaabarkergillette.com\/pk\/#\/schema\/logo\/image\/","url":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2025\/11\/eSignature_RBG_Logo.png","contentUrl":"https:\/\/riaabarkergillette.com\/pk\/assets\/uploads\/2025\/11\/eSignature_RBG_Logo.png","width":85,"height":72,"caption":"RIAA Barker Gillette"},"image":{"@id":"https:\/\/riaabarkergillette.com\/pk\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/riaabarkergillette.com\/pk\/#\/schema\/person\/45cef49fa13e3c1a6c7c7b7e53d6a34b","name":"Mayhar Kazi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0a4e6997fee70574dadadba04bb3989eccddf86eb22d87b64e89372cb500e5b2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0a4e6997fee70574dadadba04bb3989eccddf86eb22d87b64e89372cb500e5b2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0a4e6997fee70574dadadba04bb3989eccddf86eb22d87b64e89372cb500e5b2?s=96&d=mm&r=g","caption":"Mayhar Kazi"}}]}},"_links":{"self":[{"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/posts\/17720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/comments?post=17720"}],"version-history":[{"count":2,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/posts\/17720\/revisions"}],"predecessor-version":[{"id":17724,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/posts\/17720\/revisions\/17724"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/media\/17725"}],"wp:attachment":[{"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/media?parent=17720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/categories?post=17720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/riaabarkergillette.com\/pk\/wp-json\/wp\/v2\/tags?post=17720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}